Scholars Central

EditorialPublished 22 Sep 2016

Recent Advances in Hodgkin Lymphoma

Authors: Theodoros P Vassilakopoulos, Sotirios G Papageorgiou

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hodgkin lymphoma (HL) is considered as a highly curable malignancy, but successful treatment can be associated with significant long-term toxicity. Traditional treatment modalities include chemotherapy, radiotherapy (RT) and salvage chemotherapy with autologous stem cell transplantation (ASCT). The goal of modern treatment is focused on tailoring each patient’s approach according to age, risk of relapse and risk of short- and long-term toxicity.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Blood Research & Hematologic Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Blood Research & Hematologic Diseases
  • SubjectHaematology
  • BylineArticles whose byline prints “Theodoros P Vassilakopoulos”
  • BylineArticles whose byline prints “Sotirios G Papageorgiou”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels